Literature DB >> 17460453

The pathology of gastric cardia: a prospective, endoscopic, and morphologic study.

Renzo Cestari1, Vincenzo Villanacci, Gabrio Bassotti, Elisa Rossi, Domenico Della Casa, Guido Missale, Luigi Minelli, Paolo Cengia, Marco Gambarotti, Francesco Pirali, Francesco Donato, Robert M Genta.   

Abstract

"Carditis" (inflammation of the gastric cardiac mucosa) may be associated with gastroesophageal reflux disease (GERD), whereas other studies argue that Helicobacter pylori could play a significant role in the chronic cardiac damage. We examined prospectively histologic features of gastric cardia, esophagitis, and H. pylori status in 204 consecutive subjects with GERD symptoms (57.3% male, 42.7% female mean age 49.2 y) undergoing upper gastrointestinal endoscopy with multiple biopsies in the distal esophagus, cardiac region, and stomach. These were assessed for esophagitis landmarks [Ismail Beigi grading (g0-3)], gastritis, and H. pylori infection (Sydney classification). The average symptom duration was 10.8 months. Endoscopy showed no erosive disease in 54.5% patients, grade "A" esophagitis in 37.6%, "B" in 8%, and "C" in 1 case. Histologic examination disclosed g0 in 8.3% patients, g1 in 78.4%, g2 in 12.8%, and g3 in 1; analysis of the cardia showed oxyntic mucosa in 27.9% patients and chronic cardiac mucosa inflammation in 72.1%. Carditis was significantly related to macroscopic esophagitis (P=0.044) and heartburn score (P=0.001). H. pylori cardiac infection was present in 27.4% cases (73.2% associated with cardiac mucosa). Gastric H. pylori infection was demonstrated in 35% patients. H. pylori in the cardiac region was associated with gastric H. pylori infection (P=0.001) and with paucity of GERD symptoms (P=0.05). A good correlation between carditis and GERD, concerning symptoms and macroscopic esophagitis was found in this study. H. pylori-related carditis is likely to be differently compared with the GERD-related type.

Entities:  

Mesh:

Year:  2007        PMID: 17460453     DOI: 10.1097/PAS.0b013e31802c9dd5

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease.

Authors:  Claudia Ringhofer; Johannes Lenglinger; Barbara Izay; Katharina Kolarik; Johannes Zacherl; Margit Eisler; Fritz Wrba; Parakrama T Chandrasoma; Enrico P Cosentini; Gerhard Prager; Martin Riegler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells.

Authors:  Arne Kandulski; Thomas Wex; Doerthe Kuester; Klaus Mönkemüller; Ulrich Peitz; Albert Roessner; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

3.  Gastric carcinomas localized to the cardia.

Authors:  Karin E Bakkelund; Ivar S Nordrum; Reidar Fossmark; Helge L Waldum
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

4.  Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.

Authors:  N Thekkek; D M Maru; A D Polydorides; M S Bhutani; S Anandasabapathy; R Richards-Kortum
Journal:  Technol Cancer Res Treat       Date:  2011-10

5.  Nodularity-like appearance in the cardia: novel endoscopic findings for Helicobacter pylori infection.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kosuke Sakitani; Tadahiro Yamakawa; Hidenobu Watanabe; Shuntaro Yoshida; Yousuke Nakai; Keisuke Hata; Hirotoshi Ebinuma; Hidekazu Suzuki; Kazuhiko Koike
Journal:  Endosc Int Open       Date:  2020-05-25

6.  Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme.

Authors:  Felipe Donoso; Anna Beckman; Andrei Malinovschi; Helene Engstrand Lilja
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.